Langland appoints Mike Brightley as advertising creative directorLangland has appointed Mike Brightley as creative director for its advertising section. Brightley has more than 14 years Share XLangland appoints Mike Brightley as advertising creative directorhttps://pharmaphorum.com/news/langland-appoints-mike-brightley-as-advertising-creative-director/
4 principles for the future of pharma marketingCOVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? Share X4 principles for the future of pharma marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/4-principles-future-pharma-marketing/
Omnichannel customer-centric teams and the future of pharma CRMIf pharma companies are to live up to their decades-old patient-centric promises then marketing budgets need to move Share XOmnichannel customer-centric teams and the future of pharma CRMhttps://pharmaphorum.com/views-and-analysis/omnichannel-customer-centric-teams-and-the-future-of-pharma-crm/
Plugging modular content into pharma’s omnichannel strategies86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a Share XPlugging modular content into pharma’s omnichannel strategieshttps://pharmaphorum.com/whitepapers/plugging-modular-content-into-pharmas-omnichannel-strategies/
Pfizer drops the blue pill, kicks off 2021 with new DNA logoPharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – Share XPfizer drops the blue pill, kicks off 2021 with new DNA logohttps://pharmaphorum.com/news/pfizer-drops-the-blue-pill-kicks-off-2021-with-new-dna-logo/
Langland appoints Angela Rochelle to clinical trial diversity roleLangland has announced the appointment of Angela Rochelle as account director, head of diversity initiatives in clinical trials. Share XLangland appoints Angela Rochelle to clinical trial diversity rolehttps://pharmaphorum.com/news/langland-appoints-angela-rochelle-to-clinical-trial-diversity-role/
The calm after the storm: How COVID-19 is making pharma more resilientCOVID-19 is proving to be the perfect storm in terms of the supply of pharmaceutical products. But learning Share XThe calm after the storm: How COVID-19 is making pharma more resilienthttps://pharmaphorum.com/views-analysis-sales-marketing/the-calm-after-the-storm-how-covid19-is-making-pharma-more-resilient-and-accessible/
Digitally engaging doctors around the worldPharmaceutical marketing budgets are going through a period of readjustment as companies explore and exploit a myriad of Share XDigitally engaging doctors around the worldhttps://pharmaphorum.com/whitepapers/digitally-engaging-doctors-around-the-world/
Pharma brands must ‘up the ante’ in their digital presenceSince COVID-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying Share XPharma brands must ‘up the ante’ in their digital presencehttps://pharmaphorum.com/views-analysis-sales-marketing/pharma-brands-must-up-the-ante-in-their-digital-presence/
